Mandates, Meddling, and Mismanagement: The IRA’s Threat to Energy and Medicine

Health Care Costs and Drug PricingHouse Oversight and Government Reform Subcommittee on Economic Growth, Energy Policy, and Regulatory Affairs · 2025-05-20 · 119th Congress
The House Oversight Subcommittees on Economic Growth, Energy Policy, and Regulatory Affairs and on Healthcare and Financial Services held a joint hearing to examine the Inflation Reduction Act's (IRA) energy subsidies and prescription drug provisions, weighing rising cost estimates against claimed benefits to consumers and manufacturers. Begins at 1:03:57
Transcript
Highlights

Title

Joint hearing on the Inflation Reduction Act's energy and drug-pricing costs

Purpose

The House Oversight Subcommittees on Economic Growth, Energy Policy, and Regulatory Affairs and on Healthcare and Financial Services held a joint hearing to examine the Inflation Reduction Act's (IRA) energy subsidies and prescription drug provisions, weighing rising cost estimates against claimed benefits to consumers and manufacturers. Republicans argued the IRA's energy subsidies had ballooned far beyond initial CBO projections and distorted energy markets, while Democrats defended the law's drug-price caps and clean-energy investments and warned about proposed Medicaid and subsidy cuts in the pending reconciliation bill. Four outside witnesses testified on the law's budgetary, energy-market, and pharmaceutical-innovation effects. Begins at1:03:57

Who spoke

Chairman Aaron Bean (R-FL)1:03:57: Opened by citing a CBO estimate that IRA energy subsidies will add $825 billion to the deficit over 10 years, more than triple the original ~$270 billion score1:04:47, and cited Cato Institute estimates of $936 billion to $1.9 trillion by 2032 and up to $4.7 trillion by 20501:05:38; later questioned Lieberman and McBride on job creation and distributional effects of the credits1:47:181:50:15.

Ranking Member Maxwell Frost (D-FL)1:08:13: Said IRA rebates provide $14,000 for heat pumps and other efficient appliances saving families roughly $350/year1:09:02, and that 340 clean-energy projects worth $522 billion have been announced across 41 states, including many Republican districts1:09:55; later pressed Dr. Gee on fossil-fuel subsidies (~$15 billion/year) and industry profits1:55:34.

Chairman Glenn Grothman (R-WI)1:14:02: Called the IRA "corporate welfare for elites," citing a Cato estimate of nearly $2 trillion in costs and a $300 billion deficit increase by 20331:14:59; argued green tax credits mainly benefit high earners already able to afford solar or EVs1:16:13 and that the tax code compliance burden costs $300 billion annually1:16:34.

Ranking Member Kristen McDonald Rivet (D-MI)1:18:48: Opened by addressing DOJ charges against Rep. McIver1:19:15, then argued the hearing's framing was one-sided, noting Republicans retained the IRA's $35 insulin cap and $2,000 drug cost cap in their reconciliation bill1:20:29 and that CBO estimates nearly 9 million people would lose Medicaid under the GOP bill1:21:39.

Ben Lieberman, Competitive Enterprise Institute1:26:19: Testified the IRA's energy provisions were originally scored at ~$370 billion but could exceed $1 trillion per outside estimates1:27:16, and warned wind/solar intermittency plus rising EV/appliance electricity demand threaten grid reliability, citing NERC blackout warnings1:29:04; later said phase-outs rarely stick and full repeal is preferable1:33:24.

Dr. Erin Trish, USC Schaefer Center1:31:21: Said CMS spent about $3 billion negotiating Medicare drug prices that ended up close to existing net prices1:32:45, and cited research that a 10% cut in expected pharmaceutical revenue could reduce innovation 2.5–15%1:33:15; noted a 35% drop in Part D plan offerings and taxpayers now covering 83% of premiums, up from 75% historically1:34:421:35:08.

Dr. William McBride, Tax Foundation1:36:33: Said JCT's initial $271 billion estimate for IRA credits (2023–2031) roughly doubled nine months after enactment and some credits, like EVs, more than quadrupled1:38:15; said the latest tax-expenditure estimate is about $1.2 trillion, and Cato's range is $900 billion to $2 trillion by 20321:39:32; cited Jason Furman's estimate of an $11,000 benefit for the top 1% in 2027 versus under $100 for the bottom 20%1:40:33.

Dr. Emily Gee, Center for American Progress1:42:06: Said the IRA's $2,000 out-of-pocket drug cap saves 11 million beneficiaries an average of $6001:42:30 and $321 billion in private clean-energy investment has already occurred with 2,300 new facilities opened1:44:13; warned the reconciliation bill's Medicaid cuts and marketplace subsidy expiration would leave 14 million more Americans uninsured by 20341:45:19.

Rep. Paul Gosar (R-AZ)2:09:36: Argued the IRA improperly used tax expenditures to fund what amounts to spending, noting about $300 billion of IRA credits are scored as outlays via direct pay2:11:18; questioned disparities between traditional and COVID-expansion Medicaid match rates2:13:06.

Rep. Emanuel Cleaver (D-MO)2:15:39: Cited $35 million invested in his district for 700+ mixed-income energy-efficient housing units2:16:27 and that 348,000 Missourians save an average $462/year on prescriptions under the IRA2:18:47; linked recent St. Louis tornado damage to the need for resilient housing investment2:17:23.

Rep. Morgan McGarvey (D-VA) — wait, transcript says "Mr. Magcguire"2:20:51: Alleged EPA found $20 billion parked improperly for activist groups tied to Stacey Abrams2:21:20; asked Lieberman why IRA cost estimates were so wrong compared to Goldman Sachs and Cato projections2:22:18.

Rep. Sydney Kamlager-Dove (D-CA) — labeled "Miss Simon" in transcript2:27:03: Described a constituent whose child has lymphoma and depends on Medicaid2:27:58; said over 10 million Americans would lose health coverage under the reconciliation bill2:28:56.

Chairman Rothman2:32:27: Asked Lieberman about repealing green energy subsidies versus phasing them out, framing phase-outs as vulnerable to lobbying extensions2:32:54; cited IRS data showing $5.5 billion of $8.4 billion in residential energy credits went to filers earning over $100,0002:36:36.

Rep. Yassamin Ansari (D-AZ)2:38:00: Said the IRA spurred $130 billion in private investment and 400,000 jobs in Republican districts2:38:00, and that a $1.25 billion project with 6,400 jobs in Rep. Gosar's district was cancelled amid policy uncertainty2:39:10; cited Rhodium Group's estimate of a 7% household energy cost increase if IRA credits are repealed2:41:08.

Rep. Chris Higgins (R-LA) — "Mr. Higgins"2:44:29: Emphasized the $37 trillion national debt and said a $1 billion annual surplus would take years to make a dent2:46:43; asked Lieberman and McBride whether energy investment would continue absent subsidies2:48:00.

Rep. Dave Min (D-CA)2:50:26: Noted the "big beautiful bill" is projected to double the national debt by 20542:50:57 and cited a prior hearing where Republican witnesses agreed the IRA incentivized US manufacturing2:51:26; pressed Trish on whether NIH/FDA cuts and immigration policy, not the IRA, were the chief concerns raised by his district's life-sciences companies2:55:16.

Rep. Lauren Boebert (R-CO)2:56:53: Argued the IRA disproportionately benefits Chinese solar/wind supply chains2:57:34 and cited a $4.6 trillion cost estimate by 20502:58:32; raised NERC blackout warnings and the Spain/Portugal blackouts as reliability risks2:59:33.

Rep. Gary Palmer (R-AL)3:02:00: Cited a 29.4% rise in electricity costs during the Biden administration3:02:31 and an Economist estimate of 68,000 excess European winter deaths tied to high energy costs3:03:53; argued for nuclear and hydrocarbon investment over renewables given AI data-center demand3:04:48.

Rep. Scott Perry (R-PA)3:07:34: Used a "manufacturing dog crap" analogy to argue subsidies attract investment regardless of merit3:08:01 and said electricity bills have risen faster than inflation since 2022 per EIA data3:12:09.

Key moments

Bean cited CBO's original $270 billion IRA energy subsidy estimate ballooning to $825 billion over 10 years, more than triple the initial score1:05:15.

McBride said JCT's initial $271 billion estimate roughly doubled within nine months of enactment, with EV and manufacturing credits more than quadrupling, reaching a current estimate near $1.2 trillion1:38:441:39:32.

McBride and Bean agreed the top 1% of earners gain roughly $11,000 from IRA credits in 2027 versus under $100 for the bottom 20%, which McBride called "a tax cut for the rich"2:02:032:25:34.

McDonald Rivet confronted Lieberman with quotes from Sen. Murkowski, Sen. Graham, and Pope Leo affirming climate change is real, saying CEI's position "sounds increasingly fringe"2:04:49.

Christian Murthy pressed McBride and Gee on the House GOP bill's roughly $625 billion in Medicaid cuts, displaying a map of rural hospitals in Illinois, Wisconsin, and Missouri at risk of closure2:08:102:08:40.

Trish testified Part D plan offerings fell 35% this year and taxpayer premium subsidization rose from a historical 75% to 83%, plus an unexpected $5 billion in added CMS subsidies1:34:421:35:38.

Ansari said a $1.25 billion, 6,400-job project in Rep. Gosar's own district was cancelled due to financial uncertainty tied to Trump administration attacks on the IRA and GOP repeal plans2:39:39.

Min noted every witness — including all three Republican witnesses — at a prior manufacturing hearing agreed the IRA's clean-energy credits incentivized US manufacturing jobs2:51:51.

Lieberman said wind and solar clean-electricity credits are effectively uncapped, with no dollar limits and no sunset until US emissions fall to 25% of 2022 baseline levels, a target he called possibly unreachable "ever"1:28:06.

Perry's exchange with McBride: McBride confirmed outside estimates of the IRA's cost ranged near $1.2 trillion versus CBO's original $370 billion, prompting Perry's "dog crap" analogy that subsidies of that scale would incentivize almost any activity3:07:343:12:38.

Metadata

CommitteeHouse Oversight and Government Reform Subcommittee on Economic Growth, Energy Policy, and Regulatory Affairs
Chamber / CongressHouse · 119th Congress
Date2025-05-20
TypeHearing
Witnesses
Dr. Emily Gee, Ph.D. — Senior Vice President / Inclusive Growth, Center for American Progress
Mr. Ben Lieberman — Senior Fellow, Competitive Enterprise Institute
Dr. William McBride, Ph.D. — Chief Economist and Stephen J. Entin Fellow in Economics, Tax Foundation
Dr. Erin Trish, Ph.D. — Co-Director, USC Schaeffer Center / Associate Professor, Department of Pharmaceutical and Health Economics, USC Mann School of Pharmacy
Videoyoutube
Transcript293 caption blocks · 20,715 words · 3:12:57 runtime
EventCongress.gov 118279